174 related articles for article (PubMed ID: 4355214)
1. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
Borsos T; Rapp HJ
J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
[No Abstract] [Full Text] [Related]
2. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
Minden P; McClatchy JK; Wainberg M; Weiss DW
J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
[No Abstract] [Full Text] [Related]
3. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
[No Abstract] [Full Text] [Related]
4. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
Bucana C; Hanna MG
J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
[No Abstract] [Full Text] [Related]
5. Vertical transmission of tumour resistance in guinea pigs.
Wainberg MA; Minden P; Weiss DW
Nature; 1976 Jan; 259(5540):213-5. PubMed ID: 175279
[No Abstract] [Full Text] [Related]
6. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
Osteen RT; Piessens WF; David JR; Churchill WH
J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune responses to tumor-specific antigens in strain-2 guinea pigs.
Smith HG; Leonard EJ
J Natl Cancer Inst; 1974 Jul; 53(1):187-94. PubMed ID: 4366195
[No Abstract] [Full Text] [Related]
8. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
Boyle MD; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
10. Antigenic analysis between BCG and tumor cells by BCG-monoclonal antibodies.
Sasaki J; Kitagawa M; Tamagake T; Narita S; Ahsan CR; Lu CL
Microbiol Immunol; 1989; 33(11):951-5. PubMed ID: 2687649
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to bacterial and tumor-derived antigens in sera from normal guinea pigs.
Brunda MJ; Minden P
J Immunol; 1977 Oct; 119(4):1374-7. PubMed ID: 197169
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
Wainberg MA; Deutsch V; Weiss DW
Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumor resistance with BCG-associated tumor antigen.
Crum ED; McGregor DD
Int J Cancer; 1977 Nov; 20(5):805-12. PubMed ID: 200576
[TBL] [Abstract][Full Text] [Related]
15. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
Ahsan CR; Sasaki J
FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
Minden P; Mathews HL; Kelleher PJ
J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
[No Abstract] [Full Text] [Related]
17. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.
Bartlett GL; Zbar B
J Natl Cancer Inst; 1972 Jun; 48(6):1709-26. PubMed ID: 4341405
[No Abstract] [Full Text] [Related]
18. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
19. BCG and cancer (first of two parts).
Bast RC; Zbar B; Borsos T; Rapp HJ
N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
[No Abstract] [Full Text] [Related]
20. Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).
Minden P; Wainberg M; Weiss DW
J Natl Cancer Inst; 1974 May; 52(5):1643-5. PubMed ID: 4364739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
